About glp1foryou

glp1foryou publishes what GLP-1 medication costs in the United States, built from federal open data. Every figure on the site traces to a named public dataset with a publication date, and every page links the file it came from.

Cost. What a pharmacy pays to acquire each GLP-1 product, from the CMS National Average Drug Acquisition Cost survey. NADAC publishes a rate per pricing unit. This site converts that rate to a cost per package, because a Ozempic pen holds 3 mL and a per-millilitre rate is not a number anyone can act on.

Access. How many clinicians prescribe each GLP-1 in each state and city, from Medicare Part D. What Medicaid paid per prescription in each state, from CMS State Drug Utilization.

Enforcement. Every FDA warning letter whose text names a GLP-1. Every outsourcing facility registered under section 503B, with its inspection date and Form 483 status. Every firm listed as the labeler of a GLP-1 package.

Programmes. What the online GLP-1 programmes charge, read from their own sites, with the date each price was read and a link to the page it was read from.

It is not a pharmacy, a clinic or a prescriber. It sells no medication and provides no medical advice. See the medical disclaimer.

It is not a source of retail prices. NADAC is what a pharmacy pays a wholesaler. No page on this site claims to tell you what you will pay at a counter, because the federal data does not contain that number.

Some outbound links to telehealth programmes carry a commission. Those links are marked, and the affiliate disclosure lists where they appear. Commission never affects a rating, a ranking or an order — the editorial policy states what does.

The safety register carries no commercial links at all.

The methodology page states every source, every join and every known limit. Where a figure looks wrong, the page it appears on links the original file, so the disagreement can be settled against the source rather than against us.